Century Therapeutics IPSC
NASDAQ IPSC
$1.66 +0.01 (+0.91%)
As of: Sep 30, 2026 · 1:22 PM EDT

Century Therapeutics, Inc. (IPSC) Other Operating Expenses (2020 - 2026)

Updated

Century Therapeutics' Other Operating Expenses was -$11.15 million in Q2 2026.

Analysis

Century Therapeutics, Inc. (IPSC) Other Operating Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Century Therapeutics' Other Operating Expenses was -$9.75 million through Jun 30, 2026; for FY2025, it came in at $6.76 million, up 56.3% from FY2024.

  • Other Operating Expenses shows a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $4.33 million in FY2024 (-79.7%), $21.37 million in FY2023 (+113.7%) and $10 million in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Other Operating Expenses in data going back to Q2 2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.15 Mn
Sep 30, 2025 1.40 Mn
Dec 31, 2024 4.33 Mn
Dec 31, 2023 13.15 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 4.22 Mn
Mar 31, 2022 10.00 Mn
Jun 30, 2020 4.72 Mn
API Access

Century Therapeutics, Inc. Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IPSC&period=max&api_key=YOUR_API_KEY